Bharat Parenterals Limited (NSE:BPLPHARMA)
India · Delayed Price · Currency is INR 1,800.80
-116.10 (-6.06%)
At close: Nov 9, 2026
Bharat Parenterals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 12,498 | 6,204 | 6,443 | 6,531 | 1,940 | 1,971 | |
Market Cap Growth | 51.74% | -3.69% | -1.35% | 236.59% | -1.57% | 2.67% |
Enterprise Value | 13,721 | 7,287 | 7,552 | 7,771 | 2,392 | 1,806 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 1246.75 | - | - | 44.99 | 12.35 | 9.25 |
PS Ratio | 3.17 | 1.80 | 1.89 | 2.50 | 0.89 | 0.93 |
PB Ratio | 3.91 | 1.99 | 1.90 | 2.74 | 0.89 | 1.16 |
P/TBV Ratio | 4.49 | 2.31 | 2.32 | 3.33 | 1.06 | 1.19 |
P/OCF Ratio | - | 16.17 | - | - | 8.96 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.48 | 2.11 | 2.22 | 2.98 | 1.09 | 0.85 |
EV/EBITDA Ratio | 41.72 | 45.92 | 164.68 | 28.48 | 9.30 | 5.80 |
EV/EBIT Ratio | - | - | - | 42.54 | 12.06 | 7.37 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.50 | 0.47 | 0.53 | 0.66 | 0.23 | 0.10 |
Debt / EBITDA Ratio | 4.87 | 9.21 | 39.29 | 5.77 | 1.93 | 0.57 |
Net Debt / Equity Ratio | 0.42 | 0.46 | 0.53 | 0.63 | 0.19 | -0.10 |
Net Debt / EBITDA Ratio | 4.11 | 9.11 | 39.17 | 5.46 | 1.59 | -0.55 |
Net Debt / FCF Ratio | - | -92.08 | -3.19 | -1.37 | -0.58 | 0.64 |
Asset Turnover | 0.64 | 0.55 | 0.59 | 0.61 | 0.76 | 1.00 |
Inventory Turnover | 2.76 | 2.52 | 3.05 | 3.25 | 4.76 | 6.39 |
Quick Ratio | 0.84 | 0.97 | 0.79 | 0.80 | 1.02 | 2.65 |
Current Ratio | 1.53 | 1.97 | 1.60 | 1.38 | 1.54 | 3.46 |
Return on Equity (ROE) | -2.95% | -8.39% | -15.13% | 4.61% | 8.10% | 13.57% |
Return on Assets (ROA) | -0.14% | -1.82% | -3.33% | 2.67% | 4.30% | 7.21% |
Return on Invested Capital (ROIC) | -0.31% | -3.77% | -6.79% | 3.18% | 6.43% | 13.91% |
Return on Capital Employed (ROCE) | -0.30% | -4.00% | -7.20% | 5.80% | 8.60% | 13.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.08% | -1.32% | -1.96% | 2.22% | 8.10% | 10.81% |
FCF Yield | - | -0.25% | -8.74% | -16.69% | -36.05% | -13.61% |
Dividend Yield | 0.06% | 0.11% | 0.11% | 0.09% | 0.22% | - |
Payout Ratio | 69.23% | - | - | 2.98% | - | - |
Buyback Yield / Dilution | -66.53% | -5.16% | -12.58% | -0.82% | -0.60% | -0.19% |
Total Shareholder Return | -66.47% | -5.05% | -12.47% | -0.73% | -0.37% | -0.19% |